Legal Representation
Attorney
Allyn Taylor, Esq.
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 13, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 13, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 11, 2010 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 16, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 16, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 9, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 8, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 7, 2010 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jul 7, 2009 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 7, 2009 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 7, 2009 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 7, 2009 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 17, 2009 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
| Jun 17, 2009 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Jun 16, 2009 | LOPT | I | LETTER OF PROTEST EVIDENCE FORWARDED | Loading... |
| Jun 9, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 17, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 25, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 7, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 7, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 28, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 28, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 30, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005